TIRCON International NBIA Registry

Last updated: December 15, 2023
Sponsor: LMU Klinikum
Overall Status: Active - Recruiting

Phase

N/A

Condition

Nerve Injury

Treatment

N/A

Clinical Study ID

NCT05522374
TIRCON-reg
  • All Genders

Study Summary

TIRCON-reg aims to

  • continue the provision of a global registry and natural history study for NBIA disorders

  • harmonize and cover existing national and single site registries

  • enable participation of countries and single sites that so far have no access to an NBIA registry

  • join forces in order to recruit sufficient numbers of patients

  • define the natural history of NBIA disorders

  • define the most appropriate outcome measures

  • inform the design and facilitate the conduction of clinical trials

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • suspected or confirmed NBIA
  • willingness to participate

Exclusion

Exclusion Criteria:

  • unwillingness to participate

Study Design

Total Participants: 2000
Study Start date:
June 14, 2012
Estimated Completion Date:
December 31, 2040

Study Description

The TIRCON international patient registry and natural history study for patients with Neurodegeneration Associated with Brain Iron Accumulation (NBIA) was initiated and funded for the first four years by TIRCON (Treat Iron-Related Childhood-Onset Neurodegeneration), an international consortium supported by the European Union between November 1st 2011 and October 31st, 2015. Since then, the registry has been sustained through donations form Patient Organizations and industry.

Harmonization of existing data has been performed by establishing and applying matching and transformation rules. The web-based registry is now fully functional for a critically needed natural history study of all NBIA subtypes. A focus has been set on scores that are most appropriate to reflect stage and progression of disease, e.g. the Barry Albright Dystonia scale, the Patient´s Global Impression of Improvement (PGII), the Unified Parkinson Disease Rating Scale (UPDRS; parts I-III and VI) and quality-of-life scores. The natural history data are collected yearly, or in rapidly progressing cases every six months, if applicable. Patients who present to one of our centers are eligible after informed consent to participate.

Connect with a study center

  • Children's Hospital of Eastern Ontario, Division of Neurology, Department of Pediatrics

    Ottawa, K1H 8L1
    Canada

    Active - Recruiting

  • Charles University, Department of neurology

    Praha, 120 00
    Czechia

    Active - Recruiting

  • LMU Klinikum, Friedrich-Baur-Institute

    Munich, Bavaria 80336
    Germany

    Active - Recruiting

  • The Foundation of the Carlo Besta Neurological Institute, IRCCS

    Milan, 20133
    Italy

    Active - Recruiting

  • University medical Center Groningen (UMCG) Department of Neurology AB 51

    Groningen, 9700 RB
    Netherlands

    Active - Recruiting

  • The Childrens Memorial Health Institute

    Warsaw, 04-730
    Poland

    Active - Recruiting

  • University of Belgrade, Department of Movement Disorders and Degenerative Brain Diseases

    Belgrade,
    Serbia

    Active - Recruiting

  • Hospital Sant Joan de Déu, Universitat de Barcelona, Servei de Neurología

    Barcelona, 08950
    Spain

    Site Not Available

  • Hospital Vall d'Hebron - Institut de Recerca (VHIR), Pediatric Neurology, Movement Disorders

    Barcelona, 08035
    Spain

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.